Cargando…
Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway
Osteogenic differentiation (OD) of bone marrow mesenchymal stem cells (BMSCs) contributes significantly to the regeneration of bone defects. Resistin, an adipose tissue-specific secretory factor, has been shown to involve many different functions, including metabolism, inflammation, cancer, and bone...
Autores principales: | Shang, JingJing, Yu, Zhentang, Xiong, Chengwei, Zhang, Junjie, Gong, Jinhong, Yu, Changlin, Huang, Yong, Zhou, Xindie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300212/ https://www.ncbi.nlm.nih.gov/pubmed/37389179 http://dx.doi.org/10.1016/j.isci.2023.107025 |
Ejemplares similares
-
Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage
por: Li, Jin, et al.
Publicado: (2022) -
CK1ε drives osteogenic differentiation of bone marrow mesenchymal stem cells via activating Wnt/β-catenin pathway
por: Yu, Zhentang, et al.
Publicado: (2023) -
PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011) -
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
por: Zhu, Kunrui, et al.
Publicado: (2022) -
miR-7/EGFR/MEGF9 axis regulates cartilage degradation in osteoarthritis via PI3K/AKT/mTOR signaling pathway
por: Jiang, Lifeng, et al.
Publicado: (2021)